Sarcopenia – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Sarcopenia – Drugs In Development, 2024 report and make more profitable business decisions.
Sarcopenia is an aging-associated condition which is characterized by loss of muscle mass, strength, and function. Symptoms include weakness, loss of endurance, and poor balance. Causes of sarcopenia include a loss of nerve cells, low hormone levels, and a decline in the body’s ability to convert protein to energy. Treatment includes hormone replacement therapy (HRT), exercise, and dietary supplements.
The Sarcopenia drugs in development market research report provide comprehensive information on the therapeutics under development for Sarcopenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Sarcopenia | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 58 molecules, with 53 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Sarcopenia therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Sarcopenia pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Sarcopenia treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AAVogen IncAnagenesis Biotechnologies SAS
Animuscure Co Ltd
ARMGO Pharma Inc
Asan Medical Center
Augusta University
Aventi Co Ltd
Bioleaders Corp
Biophytis SA
C&L Therapeutics Inc
Daewoong Pharmaceutical Co Ltd
Dong Wha Pharma Co Ltd
Dong-A Socio Holdings Co Ltd
Dystrogen Therapeutics SA
Elevian Inc
Elixir Pharma Co Ltd
Encell Co Ltd
Five Alarm Bio Ltd
Genflow Biosciences Srl
Gerologix Inc
Helixmith Co Ltd
ImmunoForge Co Ltd
iProgen Biotech Inc
Keren Therapeutics
Klotho Therapeutics Inc
Korea Pharma Co Ltd
Korea Research Institute of Bioscience and Biotechnology
KSbitugen Co Ltd
Lipocine Inc
MedAvail Holdings Inc
Medispan
Mirscience Therapeutics
MyMD Pharmaceuticals Inc
NMD Pharma AS
OPKO Health Inc
Pephexia Therapeutics ApS
PRG S&Tech Inc
Rejuvenate Biomed
Ridgeline Therapeutics LLC
Rubedo Life Sciences Inc
Sphaera Pharma Pte Ltd
Turn Biotechnologies Inc
Twinpigbiolab Co Ltd
University of Arkansas
Vasa Therapeutics SP Zoo
Vibe Pharmaceuticals LLC
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Sarcopenia reports